INTERNAL MEDICINE RESEARCH
Advancing liver cancer care through collaborative innovation in detection, diagnosis, and outcomes.
The Singal & Rich research group focuses on generating critical insights to improve the entire spectrum of liver cancer care. Our studies involve assessing and promoting novel practices, imaging, and blood-based biomarkers to improve risk stratification, screening, early detection and outcomes for patients with hepatocellular carcinoma and other primary liver cancers.
Meet the PIs
Amit Singal, M.D.
Medical Director of the Liver Tumor Program and Chief of Hepatology
Professor
Division of Digestive & Liver Diseases
Get Involved
Join Our Lab
If you're interested in joining our team, please reach out to learn more about open positions.
Find out more